CAJ | 학술논문

　　目的对瑞舒伐他汀联合西洛他唑治疗老年高脂血症的临床疗效进行观察和分析。方法抽取我院确诊的55例老年高脂血症患者，作为研究对象,随机分为对照组和研究组。对照组采用每天一次瑞舒伐他汀10 mg，研究组在对照组治疗的基础上，加用50 mg西洛他唑，每天2次。12周后，对治疗前后的各项指标进行比较。结果研究组效果明显优于对照组，差异有统计学意义（P＜0.05）。不良反应出现5例，但并不严重。结论瑞舒伐他汀联合西洛他唑治疗老年高脂血症，比单药瑞舒伐他汀治疗效果更佳，且不良反应小疗效可靠，适合老年高脂血症患者使用。
　　목적대서서벌타정연합서락타서치료노년고지혈증적림상료효진행관찰화분석。방법추취아원학진적55례노년고지혈증환자，작위연구대상,수궤분위대조조화연구조。대조조채용매천일차서서벌타정10 mg，연구조재대조조치료적기출상，가용50 mg서락타서，매천2차。12주후，대치료전후적각항지표진행비교。결과연구조효과명현우우대조조，차이유통계학의의（P＜0.05）。불량반응출현5례，단병불엄중。결론서서벌타정연합서락타서치료노년고지혈증，비단약서서벌타정치료효과경가，차불량반응소료효가고，괄합노년고지혈증환자사용。
Objective Rosuvastatin combined for cilostazol treatment of elderly hyperlipidemia clinical efficacy were observed and analyzed. Methods Decimation of 55 cases diagnosed in our hospital elderly patients with hyperlipidemia, as research subjects were randomly divided into control and study groups. Control group once a day Rosuvastatin 10 mg, study group were treated based on the addition of 50 mg of cilostazol twice daily. After 12 weeks, the indicators before and after treatment were compared. Result Effect of the study group was significantly better than the control group, the difference was statistically significant (P<0.05). Adverse reactions occurred in 5 cases, but it is not serious. Conclusion Rosuvastatin combined cilostazol treatment of elderly patients with hyperlipidemia, compared with single-drug therapy with rosuvastatin better, and adverse reactions effective and reliable, suitable for elderly patients with hyperlipidemia.